United States· US:42388-024_e8cdcbdc-d863-4d48-af3e-a8926b9ab017
CABOMETYX
A medicinal product containing cabozantinib s-malate, registered in United States by Exelixis, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CABOZANTINIB S-MALATE
- Manufacturer
- Exelixis, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc11423880242630 TABLET in 1 BOTTLE (42388-024-26)
- ndc11423880243715 TABLET in 1 BOTTLE (42388-024-37)
- ndc1142388024461 BOTTLE in 1 CARTON (42388-024-46) / 30 TABLET in 1 BOTTLE
- ndc1142388024571 BOTTLE in 1 CARTON (42388-024-57) / 15 TABLET in 1 BOTTLE
- ndc1142388-024-26
- ndc1142388-024-37
- ndc1142388-024-46
- ndc1142388-024-57
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cabozantinib s-malate in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Hasgobusno
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/922b89fd-c6bb-4457-9068-88a35384c276 GET /v1/drugs/922b89fd-c6bb-4457-9068-88a35384c276?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "20",
"substance": "CABOZANTINIB S-MALATE",
"productndc": "42388-024",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA208692",
"marketing_category": "NDA"
}See everything about cabozantinib s-malate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.